Objective
=========

To evaluate ICU-acquired infections, germs responsible and sensibility to antibiotics in an ICU using a patient-to-patient antibiotic rotation. We have compared our dates with EPIC study.

Methods
=======

It is a prospective study in a 20-bed medical-surgical intensive care unit. Included were all patients admitted in ICU during 19 months in two periods of time (first period from 1 January 1999 to 30 July 1999, second period from 1 May 2000 to 30 April 2001), with a length of stay in ICU longer than 24 hours. The infections were diagnosed according to CDC criteria.

Results
=======

Studied were 978 patients (371 and 607 patients in respective periods of time), 601 males and 377 females. Mean age was 57.01 ± 17.80 years. APACHE-II was 13.76 ± 6.31. Mortality was 14.21%. Patients distribution was: 46% cardiac surgery, 11% cardiologic, 10% neurologic, 10% traumathology, 8% pulmonary, 5% digestive, 10% others. We diagnosed 315 UCI-acquired infections in 182 patients. Distribution infections was: respiratory 39%, urinary tract infection 28%, central venous catheter 12%, primary bloodstream 12%, wound surgical 5%, nervous central system 4%. We isolated 322 germs: 47% Gram negative, 43% Gram positive, 10% fungi. We found the following differences between EPIC and our data: (a) rate infections for *Pseudomonas aeruginosa* 28--7.1%, for acinetobacter 9--0.3%, for fungi 17--9.9%; (b) rate resistance of pseudomonas to gentamicin 46--25%, to ureidopenicillin 37--14%, to ceftazidime 27--18%, to ciprofloxacin 26--5%, to imipenem 21--13%; (c) rate resistance of *Staphylococci aureus* to methicillin 60--17%; (d) rate resistance of coagulase-negative staphylococci to vancomycin 3--0%.

Conclusions
===========

In our ICU, with a patient-to-patient antibiotic rotation, we had no serious problems of resistance to antibiotics.
